Common blood pressure drugs linked to 33% higher kidney risk in type 2 diabetes patients

A new study found that dihydropyridine calcium channel blockers (DCCBs), a widely prescribed class of blood pressure medications, were associated with a 33% higher risk of serious kidney problems in people with type 2 diabetes, even when they were already taking kidney-protective drugs. The finding is prompting researchers to question whether DCCBs should always be the default second-line treatment for diabetic kidney disease.

Similar stories

🏥 Health Avoiding three risk factors in midlife can delay dementia by about 13 years, study finds Smithsonian Magazine · 22h ago 🏥 Health Hypertension and state benefits: daily functioning, not diagnosis, is the key factor Interia Fakty · 11d ago 🏥 Health 11 months on Ozempic: appetite vanished, but quitting brought relief Onet Wiadomości · 12d ago